Pura Vida Investments as of Sept. 30, 2015
Portfolio Holdings for Pura Vida Investments
Pura Vida Investments holds 63 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Teleflex Incorporated (TFX) | 7.6 | $13M | 108k | 124.21 | |
| CIGNA Corporation | 4.7 | $8.2M | 61k | 135.02 | |
| Universal Health Services (UHS) | 4.6 | $8.1M | 65k | 124.81 | |
| Smith & Nephew (SNN) | 4.1 | $7.2M | 205k | 35.00 | |
| Stryker Corporation (SYK) | 4.0 | $7.1M | 75k | 94.11 | |
| Boston Scientific Corporation (BSX) | 3.9 | $6.8M | 415k | 16.41 | |
| Pfizer (PFE) | 3.5 | $6.1M | 195k | 31.41 | |
| NxStage Medical | 2.8 | $4.9M | 310k | 15.77 | |
| Insulet Corporation (PODD) | 2.7 | $4.7M | 181k | 25.91 | |
| Johnson & Johnson (JNJ) | 2.7 | $4.7M | 50k | 93.36 | |
| Wright Medical | 2.5 | $4.4M | 210k | 21.02 | |
| Valeant Pharmaceuticals Int | 2.4 | $4.1M | 23k | 178.38 | |
| Abbvie (ABBV) | 2.3 | $4.0M | 74k | 54.41 | |
| Hologic (HOLX) | 2.2 | $3.9M | 100k | 39.13 | |
| Eli Lilly & Co. (LLY) | 2.1 | $3.7M | 44k | 83.68 | |
| Cyberonics | 2.1 | $3.6M | 60k | 60.78 | |
| Accuray Incorporated (ARAY) | 2.0 | $3.6M | 714k | 5.00 | |
| NuVasive | 2.0 | $3.5M | 73k | 48.21 | |
| Spectranetics Corporation | 1.9 | $3.4M | 290k | 11.79 | |
| Abbott Laboratories (ABT) | 1.8 | $3.2M | 80k | 40.22 | |
| Bristol Myers Squibb (BMY) | 1.8 | $3.2M | 54k | 59.20 | |
| Cynapsus Therapeutics | 1.8 | $3.1M | 195k | 15.95 | |
| Varian Medical Systems | 1.7 | $3.0M | 40k | 73.78 | |
| Alimera Sciences | 1.6 | $2.9M | 1.3M | 2.21 | |
| Vanda Pharmaceuticals (VNDA) | 1.6 | $2.8M | 248k | 11.28 | |
| Perrigo Company (PRGO) | 1.6 | $2.8M | 18k | 157.26 | |
| Kite Pharma | 1.6 | $2.7M | 49k | 55.67 | |
| Wright Med Group Inc right 03/01/2019 | 1.5 | $2.6M | 586k | 4.52 | |
| Endologix | 1.4 | $2.5M | 205k | 12.26 | |
| Baxalta Incorporated | 1.4 | $2.5M | 80k | 31.51 | |
| Edwards Lifesciences (EW) | 1.4 | $2.5M | 18k | 142.17 | |
| Affymetrix | 1.4 | $2.4M | 280k | 8.54 | |
| Jazz Pharmaceuticals (JAZZ) | 1.4 | $2.4M | 18k | 132.83 | |
| Owens & Minor (OMI) | 1.3 | $2.2M | 70k | 31.94 | |
| Qiagen | 1.2 | $2.2M | 85k | 25.80 | |
| Synergy Pharmaceuticals | 1.2 | $2.1M | 400k | 5.30 | |
| Alexion Pharmaceuticals | 1.1 | $2.0M | 13k | 156.40 | |
| Allergan | 1.1 | $1.9M | 7.0k | 271.86 | |
| C.R. Bard | 1.1 | $1.9M | 10k | 186.30 | |
| Transenterix | 1.1 | $1.8M | 810k | 2.26 | |
| iShares MSCI Australia Index Fund (EWA) | 1.0 | $1.8M | 100k | 17.92 | |
| Alliqua | 0.9 | $1.7M | 523k | 3.17 | |
| Zeltiq Aesthetics | 0.9 | $1.6M | 50k | 32.04 | |
| Akorn | 0.8 | $1.4M | 50k | 28.51 | |
| Sage Therapeutics (SAGE) | 0.7 | $1.2M | 28k | 42.32 | |
| Tonix Pharmaceuticls | 0.6 | $1.1M | 208k | 5.29 | |
| Penumbra (PEN) | 0.6 | $1.0M | 26k | 40.12 | |
| Flex Pharma | 0.5 | $865k | 72k | 12.01 | |
| Zogenix | 0.5 | $793k | 59k | 13.50 | |
| BioDelivery Sciences International | 0.4 | $751k | 135k | 5.56 | |
| Foamix Pharmaceuticals | 0.4 | $748k | 102k | 7.33 | |
| FEI Company | 0.4 | $730k | 10k | 73.00 | |
| Dyax | 0.3 | $449k | 24k | 19.11 | |
| Ocera Therapeutics | 0.2 | $414k | 131k | 3.16 | |
| Ptc Therapeutics I (PTCT) | 0.2 | $401k | 15k | 26.73 | |
| Cymabay Therapeutics | 0.2 | $388k | 200k | 1.94 | |
| Aldeyra Therapeutics (ALDX) | 0.2 | $335k | 58k | 5.83 | |
| Adamis Pharmaceuticals Corp Com Stk | 0.2 | $312k | 81k | 3.88 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.2 | $300k | 100k | 3.00 | |
| Carbylan Therapeutics Inc Common Stock Usd 0.001 | 0.2 | $286k | 80k | 3.58 | |
| Inotek Pharmaceuticals | 0.1 | $252k | 27k | 9.40 | |
| Lombard Med (EVARF) | 0.1 | $189k | 53k | 3.57 | |
| Sarepta Therapeutics (SRPT) | 0.1 | $173k | 5.4k | 32.04 |
